Barclays Maintains an 'Overweight' on HCA Holdings (HCA); Thoughts on Accounting Change for HITECH Revenue
Tweet
Share
E-mailGet Alerts HCA Hot Sheet
Price: $429.19 +5.64%
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays maintains an 'Overweight' on HCA Holdings (NYSE: HCA) price target of $30.00.
Barclays analyst, Adam Feinstein, said, "HCA filed an 8-K to announce that it revised its accounting for HITECH incentive payments based on SEC guidance, leading to a delay in revenue recognition of these payments. In a nutshell, HCA will recognize less revenue than expected in Q4'11, but still anticipates receiving these payments in 2012. The net result is a $0.28 reduction in Q4'11 EPS and a $210 million impact to revenue and EBITDA, but, HCA confirmed that there will be no impact on cashflow from operations. We suggest that this is a timing issue rather than a reduction in the "earnings power" of HCA over the next year. Finally, HITECH has been a source of confusion for the group following the recent Q3 earnings season, so we expect a continued level of focus on better understanding this issue. With this announcement we are reducing our 2011 EPS estimate to $2.64 (down from $2.92)."
For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.
Shares of HCA Holdings closed at $25.21 yesterday.
Barclays analyst, Adam Feinstein, said, "HCA filed an 8-K to announce that it revised its accounting for HITECH incentive payments based on SEC guidance, leading to a delay in revenue recognition of these payments. In a nutshell, HCA will recognize less revenue than expected in Q4'11, but still anticipates receiving these payments in 2012. The net result is a $0.28 reduction in Q4'11 EPS and a $210 million impact to revenue and EBITDA, but, HCA confirmed that there will be no impact on cashflow from operations. We suggest that this is a timing issue rather than a reduction in the "earnings power" of HCA over the next year. Finally, HITECH has been a source of confusion for the group following the recent Q3 earnings season, so we expect a continued level of focus on better understanding this issue. With this announcement we are reducing our 2011 EPS estimate to $2.64 (down from $2.92)."
For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.
Shares of HCA Holdings closed at $25.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- enVVeno Medical (NVNO) files $100M mixed shelf
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
